USA TODAY International Edition

So far, so good: few serious health issues from shots

- Karen Weintraub

Early safety data from the first month of COVID- 19 vaccinatio­n finds the shots are as safe as the studies suggested.

Everyone who experience­d an allergic response has been treated successful­ly, and no other serious problems have turned up among the first 22 million people vaccinated, according to the Centers for Disease Control and Prevention.

The data was collected from several tracking systems, including a voluntary one in which people who are vaccinated report their symptoms via text. Another allows people who believe they have been harmed by a vaccine to contribute their informatio­n,

and a third collects reports from medical records.

Although it’s never possible to prove something is completely safe, data from these tracking systems suggests the vaccines are not causing large numbers of unusual or dangerous results.

Wednesday, Dr. Tom Shimabukur­o, deputy director of the CDC’s Immunizati­on Safety Office, briefed a CDC advisory committee on the agency’s review of safety data collected on the two authorized vaccines.

Side effects remain a common result of both the Pfizer- BioNTech and Moderna vaccines – 70% of people who selfreport­ed said they suffered pain.

Vaccinated people have suffered health crises and even death within a few days of receiving a shot, but the rate of those events is no higher than would be expected in the general population and cannot be connected to the vaccine, the review found.

Shimabukur­o did not address reports that several people died after receiving a vaccine, including a Florida doctor and a California X- ray technologi­st.

More than 22M receive dose

More than 2 million people out of the first 22 million to receive at least one dose of vaccine reported to the V- safe, a self- reporting system involving web surveys and text messages.

Of these, more than 70% reported pain, 33% fatigue, 30% headaches, 23% muscle pain and about 11% chills, fever, swelling or joint pain.

There was little difference in reported side effects between the two vaccines, though people generally had a harder time with the second dose than the first.

More than 9,000 people reported side effects after vaccinatio­n to the CDC’s Vaccine Adverse Event Reporting System, or VAERS. The problems in slightly more than 1,000 of those reports were considered serious. The majority of complaints involved headaches, fatigue, dizziness, nausea, chills, fever and pain.

A third safety reporting system, called the Vaccine Safety Datalink, looks at medical records from nine participat­ing health care organizati­ons, including data on more than 12 million people per year. More than 162,000 people in the system have received at least one COVID- 19 shot.

In that group, there were “no signals as of January 16” of increased risk for any of 20 common conditions, which included heart attack, appendicit­is, embolisms and diseases caused by low platelet counts.

In the vaccinated group, four people reported Bell’s palsy, a form of facial paralysis seen in a small number of people in each of the vaccine trials. In the unvaccinat­ed group, there were 348 cases.

Nursing home deaths

One way to figure out whether COVID- 19 vaccines kill people is to look at the number of people expected to die over a period of time and compare that with deaths that occurred within a few days of vaccinatio­n.

VAERS received reports of 196 deaths after COVID- 19 vaccinatio­n.

Of those, 66% were residents of longterm care facilities. About 1.3 million nursing home residents were vaccinated from Dec. 21 to Jan. 18.

In a group that large followed over that length of time, 11,440 people would be expected to die of all causes. That led the CDC to conclude the much lower number of nursing home deaths were not caused by vaccinatio­n.

Barbara Bardenheie­r of the Brown University School of Public Health conducted a related study of residents at Genesis Healthcare, the largest nursing home company in the USA.

More than 7,000 Genesis residents in 118 facilities received their first vaccine dose from Dec. 18- 31. After excluding people with active COVID- 19 infections, the researcher­s found fewer deaths among the vaccinated residents compared with unvaccinat­ed ones.

“Findings suggest that short- term mortality rates appear unrelated to vaccinatio­n for COVID- 19 in skilled nursing facility residents,” according to a summary of the study’s results.

The CDC found no causal link between vaccinatio­n and deaths among younger, healthier people.

Among 13.7 million people under 65, 168 people would be expected to suffer a sudden, lethal heart attack over a typical 35- day period. By comparison, 18 such deaths were reported to VAERS among people who were vaccinated.

The risk of sickness

Tracking data suggests the vaccines are not causing large numbers of unusual or dangerous results.

Both vaccines have been shown to trigger a relatively high – though still rare – rate of severe allergic reactions.

Among 10 million people who received the Pfizer- BioNTech vaccine, 50 went into anaphylact­ic shock, a rate of five serious allergic reactions per 1 million doses. Twenty- one people out of 7.6 million who received the Moderna vaccine went into shock, a rate of 2.8 per 1 million doses. Ninety percent of these incidents occurred within a half- hour of getting a shot, and all recovered.

By comparison, for the seasonal flu shot, the rate of anaphylaxi­s is 1.3 per million shots.

Still, “the risks of getting sick from COVID- 19 are much higher than the risks of anaphylaxi­s,” CDC Director Rochelle Walensky said Wednesday.

The CDC is investigat­ing whether people who had COVID- 19 before getting the shot were more likely to have an allergic reaction.

 ?? RICARDO B. BRAZZIELL/ USA TODAY NETWORK ?? Hundreds of people who made an appointmen­t to be vaccinated against COVID- 19 stand in a line that wraps around a building at the Delco Activity Center in northeast Austin, Texas, on Jan. 23.
RICARDO B. BRAZZIELL/ USA TODAY NETWORK Hundreds of people who made an appointmen­t to be vaccinated against COVID- 19 stand in a line that wraps around a building at the Delco Activity Center in northeast Austin, Texas, on Jan. 23.

Newspapers in English

Newspapers from United States